Heart savers

Launching our new series in which two experts discuss the long and the short of an aspect of diabetes treatment or research, Professors Steve Bain (Swansea University, UK) and Michael Nauck (Ruhr University, Germany) look at primary prevention of cardiovascular disease and the emerging role of novel diabetes medications.

Pressed for time? Check out the short version.